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ABSTRACT
Background    Gingerol, the generic term for pungent 
constituents in ginger, has been used for treating vom-
iting in China. We are going to investigate the mech-
anisms of inhibitive effect of gingerol on cisplatin-in-
duced pica behaviour by studying on both peripheral and 
central levels, and the effects of gingerol on homeostasis 
of dopamine (DA) transmission: dopamine D2 receptor 
(D2R), dopamine transporter (DAT) and tyrosine hy-
droxylase (TH).
Methods    The antiemetic effect of gingerol was inves-
tigated on a vomiting model in rats induced by cisplatin 
3 mg·kg−1 intraperitoneal injection (i.p.). Rats were ran-
domly divided into the normal control group (C), simple 
gingerol control group (CG), cisplatin control group 
(V), cisplatin + metoclopramide group (M), cisplatin + 
low-dose gingerol group (GL), cisplatin + middle-dose 
gingerol group (GM) and cisplatin + high-dose gingerol 
group (GH). In observation period, rats in Groups C and 
V were pretreated with sterile saline 3 mL i.g.; rats in 
Group CG were pretreated with gingerol 40 mg·kg−1 i.g.; 
rats in Group M were pretreated with metoclopramide 
2.5 mg·kg−1 i.g.; rats in Groups GL, GM and GH were 
pretreated with gingerol 10, 20 and 40 mg·kg−1 i.g. for 3 
days, respectively. Cisplatin (3 mg·kg−1, i.p.) was admin-
istered one time after each treatment with the antiemetic 
agent or its vehicle except the Groups C and CG. The 
distribution of D2R, DAT and TH in the area postrema 
and ileum were measured by immunohistochemistry 
and quantitated based on the image analysis, and the ex-
pression of DAT and TH in the area postrema and ileum 
were measured by RT-PCR. The weights of kaolin eaten 
of the remaining rats were observed in every 6 h contin-
uously for 72 h.
Results    The weight of kaolin eaten in rats induced by 
cisplatin was significantly reduced by pretreatment with 
gingerol in a dose-dependent manner during the 0–24 
h and 24–72 h periods (P < 0.05). Gingerol markedly 
improved gastric emptying induced by cisplatin in a 
dose-dependent manner (P < 0.05), and exhibited effec-
tive dose-dependent inhibition on the increase of expres-
sion levels of D2R and TH and the decrease of expres-
sion levels of DAT in both the ileum and area postrema (P 
< 0.05).
Conclusion    Gingerol is effective on cisplatin-induced 
emesis in rats possibly by inhibiting central or peripheral 
increase of DA by inhibiting D2R, TH and accelerating 
DAT. 
Key words    dopamine 2 receptor; dopamine transport; 
gingerol; tyrosine hydroxylase; vomiting 
It is generally accepted that nausea and vomiting (eme-
sis) are components of protective mechanism by which 
the human body defends itself against ingested toxins.1 
However, chemotherapy-induced nausea and vomiting 
(CINV) is a distressing and common adverse event as-
sociated with cancer treatment2 that causes extreme dis-
comfort and seriously impairs quality of patients’ life.3 
Despite significant progress in the management of nau-
sea and vomiting associated with chemotherapy, these 
side effects continue to limit the effectiveness of cancer 
therapy and weaken the quality of life of its victims.4 
Cisplatin is one of the most effective and currently avail-
able chemotherapy agents. But it is also one of the most 
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reasons on both acute and delayed emesis if anti-emet-
ics are not given.5, 6 A lot of evidences are proved that 
cisplatin can lead many adverse events such as CINV, 
nephrotoxicity and peripheral neuropathy.7 Therefore, 
the control of nausea and vomiting is critical for the pa-
tient’s quality of life and perception of chemotherapy.
 Vomiting is caused by noxious stimulation directly 
or indirectly on the vomiting center such as gastrointesti-
nal tract, vestibular system, chemoreceptor trigger zone, 
and higher centers in the cortex and thalamus. The nerve 
impulse takes place when receptors are activated, and 
transfer to the vomiting center, so emesis is initiated.8, 
9 The chemotherapy-induced emesis is developed via 
peripheral and central systems, which are independent 
relatively, and many neurotransmitters have been impli-
cated in the pathogenesis of vomiting.10, 11 Biochemical 
signaling of emesis is much more diverse than previous-
ly believed.12 More recently, dopamine (DA) is believed 
to be a major player in the motivational aspects of nau-
sea and vomiting. The homeostasis of DA transmission 
is mainly controlled by three regulatory elements: do-
pamine D2 receptor (D2R), DA transporter (DAT) and 
tyrosine hydroxylase (TH). D2R, one receptor of DA, is 
known to activate the chemoreceptor trigger zone in the 
area postrema of the fourth ventricle floor. This results 
in efferent impulses to the medullary vomiting centre, 
which initiates vomiting.13, 14 DAT, a Na+/Cl− dependent 
plasma membrane protein at nerve endings, can rapidly 
reuptake DA, and determine the intensity and duration 
of DA transmission.15 TH, the rate-limiting enzyme for 
DA synthesis, participates in the regulation of intra- and 
extracellular DA levels.16, 17 However, studies of D2R, 
DAT and TH were mainly concentrated in Parkinson’s 
disease, obesity and so on.18–20 And researches of D2R, 
DAT and TH on vomiting have not been involved.
 Rats do not vomit. Instead, anticancer drugs induce 
kaolin ingestion behavior “pica” in rats, and it is evaluat-
ed as an index of nausea/vomiting.21 Yamamoto et al.22 
have reported that kaolin intake induced by anticancer 
drugs in rats is related to their clinical emetogenic po-
tential. In the present study, we investigated the effect of 
gingerol on cisplatin-induced kaolin intake, which is an 
index of nausea/vomiting in the rat.
 Ginger, a classical traditional Chinese herbal medi-
cine known as Zingiber officinale Rosce, has been used 
for treating vomiting for 2000 years in China. It is a 
common food for cooking for years in East Asia. Some 
evidences have proved that ginger has effect on vomit-
ing, post-operative nausea and vomiting and CINV.23–25 
Studies with experimental animals (dogs and rats) have 
shown that the various extracts of ginger and the ginger 
juice possess anti-emetic effects against CINV. Gingerol 
is the generic term for pungent constituents in ginger.26 It 
has been reported to inhibit contraction of isolated guin-
ea-pig ileum by acting on 5-hydroxytryptamine 3 (5-
HT3) receptors and this is presumed to be related to its 
antiememtic activity.27 During our previous research, we 
have already proved that gingerol has effects on vomit-
ing induced by cisplatin in minks, as well as prevented 
the high expressions of DA.28, 29 But, the antiemetic 
mechanism of gingerol remains unclear, and there are 
few reports on the study of the homeostasis of DA trans-
mission. Based on our previous studies above, we have 
guessed that gingerol can adjust the abnormal expression 
of DA in vomiting by inhibiting synthesis or accelerating 
degradation of DA.
 Therefore, in this study, we are going to investigate 
the mechanisms of inhibitive effect of gingerol on cis-
platin-induced pica behaviour by studying on both pe-
ripheral and central levels, and the effects of gingerol on 
homeostasis of DA transmission: D2R, DAT and TH.
MATERIALS AND METHODS 
Animals 
Adult male Wistar rats weighing 200 ± 20 g were pur-
chased from Shandong University Laboratory Animal 
Shelter (Jinan, China). Rats were housed in individual 
cages under controlled environmental conditions (22 ± 
2 °C relative humidity 40–60%, 12 h dark/light cycles, 
food and water ad libitum). Animals were used in the 
present study in accordance with the guidelines of the 
Shandong University Institutional Animal Care and Use 
Committee. All studies were performed with approval 
from the committee (2014012-KY). 
Reagents
Gingerol (Xi’an Realin Biotechnology, Xi’an, China) 
was dissolved in 1% tragacanth. Cisplatin (Qilu Phar-
maceutical, Jinan, China) was prepared in normal saline 
at 70 °C followed by gradual cooling to 40 °C and was 
administered immediately. Metoclopramide (Qilu Phar-
maceutical, Jinan, China). Anti-D2R, anti-DAT, anti-TH, 
and goat anti-rabbit antibody were obtained from Beijing 
Bioss Biological Technology, Beijing, China.
 Kaolin was prepared according to the method of the 
literature,30 with minor modifications. Kaolin (Tianjin 
Kemiou Chemical Reagent, Tianjin, China) was mixed 
with 7% gum arabic (Tianjin Guangfu Fine Chemical 
Research Institute, Tianjin, China) in distilled water to 
form a thick paste. The mixture was placed in a tube 
and partially dried in a dryer. The mixture was extruded 
from the tube, cut into a column of the same size as that 
for normal feed pellets, and dried completely in a dryer.
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Animal experiments
105 rats were randomly divided into the following 7 
groups: normal control group (C, n = 15), simple gin-
gerol control group (CG, n = 15), cisplatin control group 
(V, n = 15), cisplatin + metoclopramide group (M, n = 
15), cisplatin+ low-dose gingerol group (GL, n = 15), 
cisplatin+ middle-dose gingerol group (GM, n = 15) and 
cisplatin + high-dose gingerol group (GH, n = 15). In ob-
servation period, rats in Groups C and V were pretreated 
with sterile saline 3 mL i.g.; rats in Group CG were 
pretreated with gingerol 40 mg·kg−1 i.g.; rats in Group M 
were pretreated with metoclopramide 2.5 mg·kg−1 i.g.; 
rats in Groups GL, GM and GH were pretreated with 
gingerol 10, 20 and 40 mg·kg−1 i.g. for 3 days, respec-
tively. Gingerol was dissolved with 1% tragacanth. In 
the second night, rats have a 12 h fast. On the third day, 
cisplatin (3 mg·kg−1, i.p.) was administered 30 min after 
each treatment with the antiemetic agent or its vehicle 
except the Groups C and CG. After administration of 
cisplatin, rats numbered 1 to 5 in each group were sacri-
ficed to measure the gastric emptying 6 h later. 
 The weights of kaolin eaten of the remaining rats 
were observed in every 6 h continuously for 72 h. To 
measure the kaolin consumption during a 72 h period, 
the remaining kaolin in the container and kaolin spilled 
in the cage were collected, dried, and weighed every 6 h. 
 Dosages of drugs were calculated based on body 
surface area. Adult patients take metoclopramide, gin-
gerol, cisplatin 30 mg, 200 mg and 35 mg per day, re-
spectively. The body surface area conversion coefficient 
from humans to rats is 0.018. Because drug metabolism 
is not exactly the same between human and rat, we uti-
lized 3 different doses of gingerol to evaluate its efficacy. 
The concentrations of gingerols administered were cal-
culated based on body surface area. Adult patients take 
gingerols at a dose of 200 mg per day, and the average 
weight of an adult is 60 kg. The body surface area con-
version coefficient from humans to rats is 0.018; thus the 
normal dose (medium dose) of gingerols administered 
to rats was 20 mg·kg−1. In order to evaluate the dose-de-
pended effect, we use three different doses group. The 
high dose is double the medium dose, and the low dose 
is half the medium dose.
 The remaining rats were sacrificed 72 h after ad-
ministration of cisplatin. Tissues from the area postrema 
as well as the ileum were removed from rats. The rats 
were placed in a stereotaxic frame (stoelting, Wood 
Dale, IL) with their head positioned vertically according 
to the Rat Brain Atlas by Paxinos and Watson.31 Stereo-
taxic coordinates of the area postrema: 0–3 mm lateral 
to midline, 4.4–4.8 mm posterior to interaural line, 
13.68–14.08 mm posterior to bregma. 
Measurements of gastric emptying
Gastric emptying was adapted from the literatures with 
some modifications.32, 33 Briefly, after a 12 h fast, rats 
numbered 1 to 5 in each group were given 2 mL of the 
phenol red solution (0.5 mg/mL) mixed with 1.5% meth-
ylcellulose via gavage. Thirty minutes after the feed-
ing, the rat was rapidly sacrificed under pentobarbital 
anesthesia. The entire stomach was carefully isolated, 
ligated just above the cardia and below the pylorus, and 
removed. The amount of phenol red in the stomach was 
determined by measuring the absorption at 560 nm us-
ing a spectrophotometer (Shenhua instrument and meter 
factory, Shanghai, China). The percentage of gastric 
emptying was defined as the ratio between the amount 
of phenol red recovered from the stomach and the 
amount of phenol red ingested into the stomach (1-the 
amount of phenol red recovered from the stomach/ the 
amount of phenol red ingested into the stomach).
Immunohistochemistry of D2R, DAT and TH
Tissues from the area postrema as well as the ileum 
were removed from rats for immunohistochemical anal-
ysis of D2R, DAT and TH. The ileum was excised at a 
distance of 20 cm from the pylorus. The samples were 
fixed in 10% buffered formalin at 4 °C for 24–48 h. 
This was followed by cryoprotection for 12–18 h at 4 °C 
using 30% sucrose or until the samples equilibrated. The 
samples were sectioned (4 μm thick) using a freezing 
microtome (ASpZr35) and standard immunohistochem-
ical procedures were used to visualize D2R, DAT and 
TH protein. Sections were washed 4 × 10 min in PBS (pH 
7.4) at room temperature and were blocked with 10% 
normal goat serum. Sections were then incubated with 
anti-D2R, anti-TH or anti-DAT (Beijing Bioss Biolog-
ical Technology, Beijing, China) overnight on a shaker 
at room temperature. Following washing (4 × 10 min) 
with PBS, sections were incubated for 2 h with goat an-
ti-rabbit antibody. Finally, sections were washed (3 × 10 
min) in PBS, transferred onto gelatin-coated slides. Tis-
sue processed without the primary D2R antibody, DAT 
antibody of TH antibody served as a negative control. 
Adjacent sections were mounted onto plus-coated slides 
and stained using Neutral Red (0.5%), washed through a 
series of increasing alcohol concentrations, cleared with 
xylene and coverslipped with Neutral Blasam. 
 Five fields from every section were randomly se-
lected for examination using an Olympus CKX41-32PH 
microscope equipped with an imaging system (Olympus 
Optical, Japan). The distribution and staining of positive 
expression of the area postrema and ileum tissue were 
observed under 200 light microscopes. The optical den-
sities were measured by Image-Pro Plus v 6.0 software 
(Media Cybernetics, Rockville, MD). 
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RT-PCR of DAT and TH 
To measure mRNA expressions of DAT and TH in 
the area postrema and ileum tissue, the tissues in rats 
were quickly immersed in RNAlater and stored at –80 
°C. The total RNA was sequentially extracted using 
TRIZOL Reagent (Sigma-Aldrich, St. Louis, MO) ac-
cording to the manufacturer’s instruction. The RNA 
was treated with DNase (DNAfree, Ambion, Austin, 
TX) in order to remove contaminating genomic DNA, 
followed by phenol, chloroform extraction and ethanol 
precipitation. Total RNA was assessed for purity using 
the NanoDrop system. Total RNA was performed in a 
two-step procedure as described by Power SYBR Green 
PCR Master Mix kits (Applied Biosystems). Briefly, in 
the first step, cDNA was prepared from 500 ng RNA 
by reverse transcription in a final volume of 20 μL in a 
thermal cycler (Tgradient 96, Whatman Biometra, Nie-
dersachsen, Germany). The samples were incubated at 
37 °C for 60 min and 95 °C for 5 min. The cDNA was 
stored at –20 °C. The rat-specific primers for the genes 
of PPT, NEP and beta-actin were designed using Prim-
er Premier 5.0 (Premier Biosoft, Palo Alto, CA). The 
primer sequences are shown in Table 1. Primers were 
synthesized by BioAsia Corp. (Shanghai, China). In the 
second step, quantitative real-time PCR was performed 
on the LightCycler apparatus (Roche Diag Diagnostics, 
Mannheim, Germany) using Power SYBR Green. PCR 
Master Mix kits (Applied Biosystems). The reaction 
was conducted with an initial denaturing at 95 °C for 
10s, and then involved 40 cycles of 55 °C 10 s, 72 °C 
15 s, and terminated by a cooling step 30 s at 40 °C. A 
melting-curve analysis was performed to confirm the 
absence of primer dimmers in specific PCR products. 
The efficiency of RT-PCR was assessed with serial di-
lutions of a sample of cDNA from the normal control 
group. Each experiment was performed in duplicate and 
the data were analyzed using LightCycler Software 4.0 
(Roche Diagnostics). Beta-actin mRNA was used as the 
housekeeping gene, and all data are represented relative 
to its expression as fold change from control group. 
Statistical analysis
All statistical analyses were performed using SPSS 17.0 
software (SPSS, Chicago, IL). Data were expressed as 
mean ± S.E. Analysis of variance (ANOVA) was per-
formed when more than two groups were compared. 
Values of P < 0.05 were considered statistically signifi-
cant.
Table 1. The sequence of each PCR primer
Gene Forward Reverse
Beta-actin 5’- GAGGGAAATCGTGCGTGAC -3’ 5’- GGACTCATCGTACTCCTGCTTG -3’
TH 5’- GTGTTTCAATGCACCCAGTAT -3’ 5’- GTCCAATGTCCTGGGAGA -3’
DAT 5’- CTGCTCTACTTCAGCCTAT -3’ 5’- GCATGGTAGCTGTGATCC -3’
DAT, dopamine transporter; PCR, polymerase chain reaction; TH, tyrosine hydroxylase.
RESULTS
Pica induced by cisplatin 
As shown in Fig. 1, rats dosed with vehicle followed 
by cisplatin had two distinct periods of pica behaviour. 
There was an initial acute phase in 24 h after adminis-
tration with cisplatin. After this period there was a de-
layed phase last near 48 h in Group V. Metoclopramide 
significantly inhibited the pica response during 24 h 
following cisplatin injection (P < 0.05). However, there 
was no significant decrease of kaolin eaten during 24–72 
h. Gingerol dose-dependently decreased the weight of 
kaolin eaten induced by cisplatin during the 72 h ob-
servation period with significant decreases on each of 
the three test days (P < 0.05). And simple gingerol did 
not significantly induce the pica behavior, there was no 
significant difference in the weight of kaolin eaten with 
Group C.
Gastric emptying
Gastric emptying was significantly delayed after admin-
istration with cisplatin. As shown in Fig. 2, the percent-
age of gastric emptying was significantly decreased in 
Group V compared with Groups C and CG (P < 0.05), 
and the delayed gastric emptying was significantly im-
proved after the treatment with metoclopramide and 
gingerol in comparison with Group V (P < 0.05). Meto-
clopramide had better effect than low-dose and mid-
dle-dose gingerol (P < 0.05). Gingerol improved gastric 
empting in a dose dependent manner (P < 0.05).
D2R, TH and DAT immunostaining expression in 
area postrema and ileum 
D2R (Fig. 3A), TH (Fig. 4A) and DAT (Fig. 5A) staining 
intensities (Red-brown deposits indicate positive stain-
ing) were mainly situated in the mucosa and submucosa 
104
W. Qian et al.
of the ileum as well as in the neurons of the area postrema. 
Compared with Group C and CG, there were more D2R, 
TH and less DAT immunoexpressions detected in Group 
V. Metoclopramide and gingerol had significant effect 
on the expression of D2R, TH and DAT in both the area 
postrema and ileum. Gingerol markedly suppressed 
the amount of D2R and TH detected and increased the 
amount of DAT detedted in a dose-dependent manner (× 
200).
 Mean optical density values of D2R, TH and DAT 
are showed in Figs. 3B, 4B and 5B, respectively. The 
photographs generated were quantitatively analyzed the 
optical density of D2R, TH and DAT by Image-Pro Plus. 
D2R and TH expressions significantly increased after 
treated with cisplatin while DAT expressions decreased 
(P < 0.05). Metoclopramide and gingerol had significant 
reducing effect on the elevated expressions of D2R, TH 
and elevation effect on the increased expressions of DAT 
in both the area postrema and ileum (P < 0.05). The 
increase of D2R, TH expressions and decrease of DAT 
expression in the area postrema and ileum induced by 
cisplatin was significantly inhibited by gingerol in a dose 
dependent manner (P < 0.05). Metoclopramide had bet-
ter effect than low-dose and middle-dose gingerol on the 
expression of D2R (P < 0.05); had better effect than low-
dose gingerol and weaker effect than high-dose gingerol 
on the expression of TH (P < 0.05); had weaker effect 
than high-dose gingerol on the expression of DAT (P < 
0.05) both in the area postrema and ileum.
mRNA expression of TH and DAT in area postrema 
and ileum
As shown in Fig. 6, TH mRNA expression in both area 
postrema and ileum in Group V was significantly in-
creased while DAT decreased compared to that in other 
groups (P < 0.05). Metoclopramide and gingerol could 
decrease TH mRNA expression (P < 0.05) and increase 
DAT mRNA expression (P < 0.05). Metoclopramide 
had better effect than low-dose gingerol (P < 0.05). Gin-
gerol decrease TH mRNA expression and increase DAT 
mRNA expression in a dose dependent manner in both 
area postrema and ileum (P < 0.05).
DISCUSSION
Nausea and vomiting are complex protective mecha-
nisms. However, when these symptoms recur frequently, 
they can significantly reduce the quality of life and can 
also be detrimental to health.34 Chemotherapy can be a 
life-prolonging treatment for many cancer patients, but 
it is often associated with profound nausea and vomiting 
that is so distressing.35 Despite advances in anti-emetic 
therapy, chemotherapy-induced nausea and vomiting 
Fig 2. 
Fig. 1. Pica induced by cisplatin. 
Rats had two distinct periods of eating kaolin in the cisplatin 
groups, and Ginger significantly decreased the weight of kaolin 
eaten induced by cisplatin during the 72 h observation period. 
Metoclopramide significantly decreased the weight of kaolin eaten 
during 24 h following cisplatin injection, but there was no signifi-
cant decrease in the pica during 24–72 h. C: normal control group, 
pretreated with sterile saline 3 mL every day (n = 10); CG: simple 
gingerol control group, pretreated with gingerol 40 mg·kg−1 i.g. 
every day (n = 10); V: cisplatin control group, pretreated with ster-
ile saline 3 mL every day (n = 10); M: cisplatin + metoclopramide 
group, pretreated with metoclopramide 2.5 mg·kg−1  i.g. every 
day (n = 10); GL: cisplatin + low-dose gingerol group, pretreated 
with gingerol 10 mg·kg−1  i.g. every day (n = 10); GM: cisplatin + 
middle-dose gingerol group, pretreated with gingerol 20 mg·kg−1 
i.g. every day (n = 10); GH: cisplatin + high-dose gingerol group, 
pretreated with gingerol 40 mg·kg−1  i.g. every day (n = 10). i.g., 
intragastrically.
Fig. 2. Gastric emptying.
C: normal control group, pretreated with sterile saline 3 mL every 
day (n = 5); CG: simple gingerol control group, pretreated with 
gingerol 40 mg·kg−1 i.g every day (n = 5); V: cisplatin control 
group, pretreated with sterile saline 3 mL every day (n = 5); M: 
cisplatin + metoclopramide group, pretreated with metoclopra-
mide 2.5 mg·kg−1 i.g. every day (n = 5); GL: cisplatin + low-dose 
gingerol group, pretreated with gingerol 10 mg·kg−1 i.g. every day (n 
= 5); GM: cisplatin + middle-dose gingerol group, pretreated with 
gingerol 20 mg·kg−1 i.g. every day (n = 5); GH: cisplatin + high-
dose gingerol group, pretreated with gingerol 40 mg·kg−1 i.g. every 
day (n = 5). *P < 0.05 vs. Group C, ‡P < 0.05 vs. Group CG, †P < 
0.05 vs. Group V, §P < 0.05 vs. Group M, ||P < 0.05 vs. Group GL, 
¶P < 0.05 vs. Group GM. i.g., intragastrically.
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still poses a significant burden to patients undergoing 
chemotherapy.36 Metoclopramide, as a clinical drug of 
D2R antagonists, has effects on vomiting and gastroin-
testinal diseases.37 It is reported that metoclopramide, 
given in doses of 10 mg, has been shown to an effective 
prophlaxis against vomiting.38 However, a recent me-
ta-analysis showed no statistically significant amount 
of extrapyramidal symptoms, dizziness, headache, or 
sedation with this dose of metaclopramide1.39 Tradi-
tional Chinese medicines have attracted attention due 
to their distinctive biological activities without toxicity 
and/or side-effects.40 Gingerol has been shown to be 
effective antiemetics on both acute and delayed emesis 
in our previous studies.41, 42 In this study, the amount of 
consumption of kaolin was significantly reduced after 
administration with gingerol compared with the con-
trol group during the whole 72 h. And gingerol has a 
dose-dependent effect. Therefore, we had investigated 
the antiemetic efficacy of gingerol on cisplatin-induced 
vomiting model of rats. In this study, gastric emptying 
was significantly delayed after administration with cis-
platin and the delayed gastric emptying was significantly 
improved after the treatment with metoclopramide and 
gingerol. Gingerol improved gastric empting in a dose 
dependent manner.
 Dopamine receptors, specifically D2 and D3, are 
known to play a role in nausea and emesis, most likely 
through inhibition of adenylate cyclase,43 which alters 
the amount of cAMP within neurons located in the 
area postrema.44 D2R, one receptor of DA, is known 
Fig. 3. D2R immunostaining expression in area postrema and ileum.
A: Immunohistochemistry expression of D2R in area postrema and ileum. The figures above (C1, CG1, V1, M1, GL1, GM1, GH1) show 
the expression in area postrema. The figures below (C2, CG2, V2, M2, GL2, GM2, GH2) show the expression in ileum. B: Mean optical 
density values of D2R. The photographs generated were quantitatively analyzed the optical density of D2R with Image-Pro Plus. C: nor-
mal control group, pretreated with sterile saline 3 mL every day (n = 10); CG: simple gingerol control group, pretreated with gingerol 40 
mg·kg−1 i.g. every day (n = 10); V: cisplatin control group, pretreated with sterile saline 3 mL every day (n = 10); M: cisplatin + metoclopr-
amide group, pretreated with metoclopramide 2.5 mg·kg−1 i.g. every day (n = 10); GL: cisplatin + low-dose gingerol group, pretreated with 
gingerol 10 mg·kg
−1
 i.g. every day (n = 10); GM: cisplatin + middle-dose gingerol group, pretreated with gingerol 20 mg·kg−1 i.g. every day (n 
= 10); GH: cisplatin + high-dose gingerol group, pretreated with gingerol 40 mg·kg−1 i.g. every day (n = 10). *P < 0.05 vs. Group C, ‡P < 
0.05 vs. Group CG, †P < 0.05 vs. Group V, §P < 0.05 vs. Group M, ||P < 0.05 vs. Group GL, ¶P < 0.05 vs. Group GM. D2R, dopamine 
D2 receptor; i.g., intragastrically.
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to activate the chemoreceptor trigger zone in the area 
postrema of the fourth ventricle floor. This results in 
efferent impulses to the medullary vomiting centre, 
which initiates vomiting.13, 14 Metoclopramide is a potent 
D2Receptor antagonist and binds to D2 receptors in the 
area postrema.43 We have already proved that gingerol 
can reduce the expression of DA in minks.29 In this 
study, the expressions of D2R was increased after inject 
with cisplatin in both the mucosa and submucosa of the 
ileum as well as in the neurons of the area postrema. 
Metoclopramide and gingerol had significant effect on 
the expression of D2R in both the area postrema and il-
eum. Gingerol markedly suppressed the amount of D2R 
detected in a dose-dependent manner. We have got the 
consistent conclusion with our previous study that gin-
gerol can significantly inhibit cisplatin-induced vomiting 
by improve the increased D2R expression on both area 
postrema and ileum.
 DAT, a Na+/Cl− dependent plasma membrane pro-
tein at nerve endings, can rapidly reuptake DA, and de-
termine the intensity and duration of DA transmission.15 
It is extensively distributed in peripheral and central ner-
vous system and participated in many physiological pro-
cesses. K Lemmer has proved that DAT can up-regulate 
the expression of DA in neuroendocrine gastrointestinal 
tumor cells.45 The expression of DAT is associated with 
some clinical diseases, such as Parkinson’s disease,46 
and is known to play an important role in gastrointes-
tinal physiology.47 But it has not been investigated in 
CINV so far. In this study, we have measured expression 
Fig. 4. TH immunostaining expression in area postrema and ileum.
A: Immunohistochemistry expression of TH in area postrema and ileum. The figures above (C3, CG3, V3, M3, GL3, GM3, GH3) show 
the expression in area postrema. The figures below (C4, CG4, V4, M4, GL4, GM4, GH4) show the expression in ileum. B: Mean optical 
density values of TH. The photographs generated were quantitatively analyzed the optical density of TH with Image-Pro Plus. C: nor-
mal control group, pretreated with sterile saline 3 mL every day (n = 10); CG: simple gingerol control group, pretreated with gingerol 40 
mg·kg−1 i.g. every day (n = 10); V: cisplatin control group, pretreated with sterile saline 3 mL every day (n = 10); M: cisplatin + metoclopr-
amide group, pretreated with metoclopramide 2.5 mg·kg−1 i.g. every day (n = 10); GL: cisplatin + low-dose gingerol group, pretreated with 
gingerol 10 mg·kg−1 i.g. every day (n = 10); GM: cisplatin + middle-dose gingerol group, pretreated with gingerol 20 mg·kg−1 i.g. every day (n 
= 10); GH: cisplatin + high-dose gingerol group, pretreated with gingerol 40 mg·kg−1 i.g. every day (n = 10). *P < 0.05 vs. Group C, ‡P < 0.05 
vs. Group CG, †P < 0.05 vs. Group V, §P < 0.05 vs. Group M, ||P < 0.05 vs. Group GL, ¶P < 0.05 vs. Group GM. i.g., intragastrically; TH, 
tyrosine hydroxylase.
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Fig. 5. DAT immunostaining expression in area postrema and ileum.
A: Immunohistochemistry expression of DAT in area postrema and ileum. The figures above (C5, CG5, V5, M5, GL5, GM5, GH5) show 
the expression in area postrema. The figures below (C6, CG6, V6, M6, GL6, GM6, GH6) show the expression in ileum. B: Mean optical 
density values of DAT. The photographs generated were quantitatively analyzed the optical density of DAT with Image-Pro Plus. C: nor-
mal control group, pretreated with sterile saline 3 mL every day (n = 10); CG: simple gingerol control group, pretreated with gingerol 40 
mg·kg−1 i.g. every day (n = 10); V: cisplatin control group, pretreated with sterile saline 3 mL every day (n = 10); M: cisplatin + metoclopr-
amide group, pretreated with metoclopramide 2.5 mg·kg−1 i.g. every day (n = 10); GL: cisplatin + low-dose gingerol group, pretreated with 
gingerol 10 mg·kg−1 i.g. every day (n = 10); GM: cisplatin + middle-dose gingerol group, pretreated with gingerol 20 mg·kg−1 i.g. every day (n 
= 10); GH: cisplatin + high-dose gingerol group, pretreated with gingerol 40 mg·kg−1 i.g. every day (n = 10). *P < 0.05 vs. Group C, ‡P < 
0.05 vs. Group CG, †P < 0.05 vs. Group V, §P < 0.05 vs. Group M, ||P < 0.05 vs. Group GL, ¶P < 0.05 vs. Group GM. DAT, dopamine 
transporter; i.g., intragastrically.
of DAT to evaluate the mechanism why gingerol can im-
prove vomiting by regulating the abnormal expression of 
DA. DAT mRNA expression in both area postrema and 
ileum in Group V was significantly decreased compared 
to that in other groups. Metoclopramide and gingerol 
could increase it. Gingerol increase DAT mRNA expres-
sion in a dose dependent manner in both area postrema 
and ileum. And the expression of DAT has positive cor-
relation with DA. 
 Except D2R and DAT, we have also analyzed TH 
to explore the mechanism of DA and vomiting. A lot of 
enzymes are involved in the metabolism of the DA. TH, 
the rate-limiting enzyme for DA synthesis, participates 
in the regulation of intra- and extracellular DA levels.16, 
17 Some evidences reveal that TH and DA have negative 
correlation on Parkinson disease48 and gastroparesis.49 
In the present research, we measure the expression of 
TH by both immunohistochemistry and RT-PCR. The 
results illustrate that metoclopramide and gingerol could 
decrease TH immunostaining expression and mRNA 
expression. By considering the similar changes of D2R 
and TH, we have inferred that gingerol has effect on 
D2R, TH and DAT to regulate the abnormal expression 
of DA on the treatment of vomiting induced by cisplatin 
in rats. 
 In present findings, gingerol has showed efficacy 
effects on vomiting induced by cisplatin. Gingerol could 
efficiently reduce DA expression by inhibiting synthesis 
and accelerating decomposition by adjusting mRNA 
associated with DA, such as D2R, DAT and TH. On 
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Fig 6. 
Fig. 6. Changes of mRNA expression of TH and DAT in area postrema and ileum.
Levels of TH and DAT against beta-actin mRNA expression are shown in the above histogram. The left-side graphs show the expression 
in area postrema. The right-side graphs show the expression in ileum. C: normal control group, pretreated with sterile saline 3 mL every 
day (n = 10); CG: simple gingerol control group, pretreated with gingerol 40 mg·kg−1 i.g. every day (n = 10); V: cisplatin control group, 
pretreated with sterile saline 3 mL every day (n = 10); M: cisplatin + metoclopramide group, pretreated with metoclopramide 2.5 mg·kg−1 
i.g. every day (n = 10); GL: cisplatin + low-dose gingerol group, pretreated with gingerol 10 mg·kg−1 i.g. every day (n = 10); GM: cisplatin 
+ middle-dose gingerol group, pretreated with gingerol 20 mg·kg−1 i.g. every day (n = 10); GH: cisplatin + high-dose gingerol group, pre-
treated with gingerol 40 mg·kg−1 i.g. every day (n = 10). *P < 0.05 vs. Group C, ‡P < 0.05 vs. Group CG, †P < 0.05 vs. Group V, §P < 0.05 
vs. Group M, ||P < 0.05 vs. Group GL, ¶P < 0.05 vs. Group GM. DAT, dopamine transporter; i.g., intragastrically; TH, tyrosine hydroxy-
lase.
the other hand, the effect of gingerol showed stronger 
effects than metaclopramide on expressions of DAT and 
TH when using at the higher dosage. According to that 
metaclopramide is a clinical drug of D2R antagonists 
on emesis,37 as well as amount of side effects,39 we 
speculate that gingerol has more comprehensive effects 
than metaclopramide on emesis and vomiting, while 
gingerol can regulate the abnormal expression of DA by 
inhibiting synthesis and accelerating decomposition by 
adjusting mRNA or enzymes associated with DA, such 
as D2R, DAT and TH.
 Nevertheless, the reason why gingerol can modulate 
expression of D2R, DAT and TH not only in the ileum 
but also area postrema remains unclear. Because the 
mRNA levels were changed, it might be modulated in 
the transcriptional step or others. This research might be 
partly proved the effect on cisplatin-induced pica analo-
gous to emesis via modulating expressions of D2R, DAT 
and TH in the vomiting model of rats. For the further 
more study of underlying molecular biological mech-
anisms, we will use the Western blot method combine 
with RT-PCR method in the next experiment.
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